[{"orgOrder":0,"company":"Chong Kun Dang Pharm","sponsor":"Choline Alfoscerate Re-evaluation Consortium","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"SOUTH KOREA","productType":"Miscellaneous","year":"2021","type":"Inapplicable","leadProduct":"Glycerylphosphorylcholine","moa":"phosphoro-derivatives","graph1":"Neurology","graph2":"Phase IV","graph3":"Chong Kun Dang Pharm","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Chong Kun Dang Pharm \/ Choline Alfoscerate Re-evaluation Consortium","highestDevelopmentStatusID":"11","companyTruncated":"Chong Kun Dang Pharm \/ Choline Alfoscerate Re-evaluation Consortium"},{"orgOrder":0,"company":"Chong Kun Dang Pharm","sponsor":"Choline Alfoscerate Re-evaluation Consortium","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"SOUTH KOREA","productType":"Miscellaneous","year":"2021","type":"Inapplicable","leadProduct":"Glycerylphosphorylcholine","moa":"phosphoro-derivatives","graph1":"Neurology","graph2":"Phase IV","graph3":"Chong Kun Dang Pharm","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Chong Kun Dang Pharm \/ Choline Alfoscerate Re-evaluation Consortium","highestDevelopmentStatusID":"11","companyTruncated":"Chong Kun Dang Pharm \/ Choline Alfoscerate Re-evaluation Consortium"},{"orgOrder":0,"company":"Daewoong Bio","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"SOUTH KOREA","productType":"Miscellaneous","year":"2022","type":"Inapplicable","leadProduct":"Glycerylphosphorylcholine","moa":"phosphoro-derivatives","graph1":"Neurology","graph2":"Phase IV","graph3":"Daewoong Bio","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Daewoong Bio \/ Undisclosed","highestDevelopmentStatusID":"11","companyTruncated":"Daewoong Bio \/ Undisclosed"}]

Find Clinical Drug Pipeline Developments & Deals for Glycerylphosphorylcholine

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          Formnext Forum
                          Not Confirmed
                          Formnext Forum
                          Not Confirmed

                          Details : Choline Alfoscerate is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Alzheimer Disease.

                          Product Name : Undisclosed

                          Product Type : Miscellaneous

                          Upfront Cash : Inapplicable

                          May 20, 2022

                          Lead Product(s) : Glycerylphosphorylcholine

                          Therapeutic Area : Neurology

                          Highest Development Status : Phase IV

                          Sponsor : Undisclosed

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          02

                          Formnext Forum
                          Not Confirmed
                          Formnext Forum
                          Not Confirmed

                          Details : Choline Alfoscerate is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Vascular Cognitive Impairment.

                          Product Name : Undisclosed

                          Product Type : Miscellaneous

                          Upfront Cash : Inapplicable

                          September 20, 2021

                          Lead Product(s) : Glycerylphosphorylcholine

                          Therapeutic Area : Neurology

                          Highest Development Status : Phase IV

                          Sponsor : Choline Alfoscerate Re-evaluation Consortium

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          03

                          Formnext Forum
                          Not Confirmed
                          Formnext Forum
                          Not Confirmed

                          Details : Choline Alfoscerate is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Cognitive Dysfunction.

                          Product Name : Undisclosed

                          Product Type : Miscellaneous

                          Upfront Cash : Inapplicable

                          September 13, 2021

                          Lead Product(s) : Glycerylphosphorylcholine

                          Therapeutic Area : Neurology

                          Highest Development Status : Phase IV

                          Sponsor : Choline Alfoscerate Re-evaluation Consortium

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          04

                          Formnext Forum
                          Not Confirmed
                          Formnext Forum
                          Not Confirmed

                          Details : Choline Alfoscerate is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Alzheimer Disease.

                          Product Name : Undisclosed

                          Product Type : Miscellaneous

                          Upfront Cash : Inapplicable

                          February 22, 2018

                          Lead Product(s) : Glycerylphosphorylcholine

                          Therapeutic Area : Neurology

                          Highest Development Status : Phase IV

                          Sponsor : Undisclosed

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          05

                          Formnext Forum
                          Not Confirmed
                          Formnext Forum
                          Not Confirmed

                          Details : Choline Alfoscerate is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Alzheimer Disease.

                          Product Name : Undisclosed

                          Product Type : Miscellaneous

                          Upfront Cash : Inapplicable

                          January 07, 2016

                          Lead Product(s) : Glycerylphosphorylcholine

                          Therapeutic Area : Neurology

                          Highest Development Status : Phase IV

                          Sponsor : Undisclosed

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank